Disease/Infection News

RSS

Pediatric cardiologists offer advice on when kids can return to sports after COVID-19

A trio of pediatric cardiologists is offering important advice on if and when it is safe for children and teens to return to playing sports after recovering from COVID-19.

12 Aug 2020

Machine learning helps detect new potential drugs to treat COVID-19

Scientists at the University of California, Riverside, have used machine learning to identify hundreds of new potential drugs that could help treat COVID-19, the disease caused by the novel coronavirus, or SARS-CoV-2.

12 Aug 2020

Experimental vaccine effective at preventing pneumonia in COVID-19-infected mice

An experimental vaccine is effective at preventing pneumonia in mice infected with the COVID-19 virus, according to a study from Washington University School of Medicine in St. Louis.

12 Aug 2020

Novel strategy provides new hope to fight COVID-19

A novel strategy has been developed by Novateur Ventures, which provides new hope in battle against COVID-19. The study titled 'A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-19 by Targeting Leukotrienes' was published in Frontiers in Pharmacology, a leading peer-reviewed journal.

12 Aug 2020

Creating a blood test for the detection of Alzheimer’s disease

News-Medical spoke to Dr. Randall Bateman and Dr. Nicolas Barthélemy about their research on Alzheimer's disease, and their new diagnosis technique.

12 Aug 2020

Nurses and doctors sick with COVID feel pressured to get back to work

The first call in early April was from the testing center, informing the nurse she was positive for COVID-19 and should quarantine for two weeks.

12 Aug 2020

Bereaved families are ‘the secondary victims of COVID-19’

Every day, the nation is reminded of COVID-19's ongoing impact as new death counts are published. What is not well documented is the toll on family members.

12 Aug 2020

C-type lectin receptors play a role in SARS-CoV-2 infection

A new study published on the preprint server bioRxiv in August 2020 confirms and extends earlier findings showing that a type of sugar-based receptor on innate immune cells promotes the entry of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) into other cells that carry the viral receptor, angiotensin-converting enzyme 2 (ACE2).

12 Aug 2020

Study: High blood sugar may trigger worse outcomes in COVID-19 patients

As COVID-19 continues to rage across the U.S., researchers are digging deeper into how the virus wreaks havoc on the body, especially for those with a pre-existing chronic illness.

12 Aug 2020

Study reveals new clues about SARS-CoV-2 infection

Working together, researchers at McMaster University and the University of Waterloo are searching for how the SARS-CoV-2 virus infects the lungs - and they're challenging what has become an accepted truth about the virus.

12 Aug 2020

Open access journal posts COVID-19 preprint studies to reduce misinformation

Today, open access journal Rapid Reviews: COVID-19 (RR:C19), published by the MIT Press, posted peer reviews of eight COVID-19 preprint studies in an effort to reduce misinformation and to elevate noteworthy and useful research for scientists, public health officials, journalists, and the public.

12 Aug 2020

New model predicts which COVID-19 patients are at higher risk for hospitalization

Cleveland Clinic researchers have developed and validated a risk prediction model (called a nomogram) that can help physicians predict which patients who have recently tested positive for SARS-CoV-2, the virus that causes COVID-19, are at greatest risk for hospitalization.

12 Aug 2020

Research looks at convalescent plasma use in COVID-19 mouse model

A new study by researchers at the University of Iowa and published on the preprint server bioRxiv in August 2020 reports the utility of a mouse model that recapitulates several aspects of human COVID-19 and can reflect the antiviral efficacy of new drugs as well.

12 Aug 2020

Study identifies three potential drugs to eradicate parasitic worms

Scientists have revealed a way to eradicate parasitic worms by stopping them from using alternative metabolism pathways provided by bacteria that live within them, according to new findings published today in eLife.

12 Aug 2020

SARS-CoV-2 a "swarm" of mutant viruses

In this new study, the virus was serially passaged in independent cell types in a controlled environment. The researchers found that the virus rapidly adapts to the changing conditions in culture by selecting for pre-existing species.

12 Aug 2020

Study highlights need to understand different environmental conditions that affect surface chemistry of SARS-CoV-2

Researchers at Michigan Tech, TÜV SÜD UK National Engineering Laboratory and University of Edinburgh call for increased research on virus surface stability and interaction in "Surface Chemistry Can Unlock Drivers of Surface Stability of SARS-CoV-2 in Variety of Environmental Conditions" in the Cell Press journal Chem.

12 Aug 2020

Can SARS-CoV-2 be transmitted via feces?

A new study by researchers at the University of Oxford and the Trip Medical Database and published on the preprint server medRxiv* in August 2020 as part of the ongoing Open Evidence Review on Transmission Dynamics of COVID-19 reports the presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in feces and the need for precautions to prevent orofecal spread in the surroundings of confirmed or suspected cases.

12 Aug 2020

Smoking and vaping significantly increase risk of COVID-19 in teens and young adults

Now, a new study published in the Journal of Adolescent Health shows that teens and young adults may have a heightened risk of COVID-19 if they vape or smoke cigarettes. Cigarette smokers are seven times more likely to be infected with SARS-CoV-2. Meanwhile, people who vape are five times more likely to be diagnosed with the viral infection.

11 Aug 2020

Scientist explains why COVID-19 targets only some organs while others are spared

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses the enzyme angiotensin-converting enzyme 2 (ACE2) to enter and infect human cells. It causes COVID-19 and can lead to a multitude of complications, including multi-organ impairment, partially due to the abundant expression of ACE2 in all human tissues.

11 Aug 2020

Focusing on human enzymes and not SARS-CoV-2 could help treat COVID-19

Now, breakthrough research into malaria suggests targeting enzymes from the human host, rather than from the pathogen itself. The new research could pave the way for effective treatments for a wide range of infectious diseases, including the coronavirus disease (COVID-19).

11 Aug 2020